InvestorsHub Logo
Followers 14
Posts 1081
Boards Moderated 0
Alias Born 01/24/2018

Re: None

Tuesday, 04/14/2020 3:10:18 PM

Tuesday, April 14, 2020 3:10:18 PM

Post# of 26271
New tweet

Our joint venture with Premier Biomedical, Inc. encompasses the patent for the Sequential Extracorporeal Treatment of Bodily Fluids, US Patent No. 9,216,386, and Utilization of Stents for the treatment of Blood Borne Carcinomas, U.S. Patent No. 8,758,287 premierbiomedical.com.